Moss SE, Klein R, Klein BE: Cause-specific mortality in a population-based study of diabetes. Am J Public Health. 1991, 81 (9): 1158-1162.
Article
PubMed Central
CAS
PubMed
Google Scholar
Turner R, Cull C, Holman R: United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus. Ann Intern Med. 1996, 124 (1 Pt 2): 136-145.
Article
CAS
PubMed
Google Scholar
Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M: Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998, 339 (4): 229-234. 10.1056/NEJM199807233390404.
Article
CAS
PubMed
Google Scholar
Kannel WB, McGee DL: Diabetes and cardiovascular disease. The Framingham study. Jama. 1979, 241 (19): 2035-2038. 10.1001/jama.241.19.2035.
Article
CAS
PubMed
Google Scholar
ETDRS I: Aspirin effects on mortality and morbidity in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report 14. ETDRS Investigators. Jama. 1992, 268 (10): 1292-1300. 10.1001/jama.268.10.1292.
Article
Google Scholar
Gaspoz JM, Coxson PG, Goldman PA, Williams LW, Kuntz KM, Hunink MG, Goldman L: Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease. N Engl J Med. 2002, 346 (23): 1800-1806. 10.1056/NEJM200206063462309.
Article
PubMed
Google Scholar
Harpaz D, Gottlieb S, Graff E, Boyko V, Kishon Y, Behar S: Effects of aspirin treatment on survival in non-insulin-dependent diabetic patients with coronary artery disease. Israeli Bezafibrate Infarction Prevention Study Group. Am J Med. 1998, 105 (6): 494-499. 10.1016/S0002-9343(98)00328-3.
Article
CAS
PubMed
Google Scholar
Nobles-James C, James EA, Sowers JR: Prevention of cardiovascular complications of diabetes mellitus by aspirin. Cardiovasc Drug Rev. 2004, 22 (3): 215-226.
Article
CAS
PubMed
Google Scholar
Aspirin for the primary prevention of cardiovascular events: recommendation and rationale. Ann Intern Med. 2002, 136 (2): 157-160.
Hennekens CH, Dyken ML, Fuster V: Aspirin as a therapeutic agent in cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation. 1997, 96 (8): 2751-2753.
Article
CAS
PubMed
Google Scholar
ADA: Aspirin therapy in diabetes. American Diabetes Association. Diabetes Care. 1997, 20 (11): 1772-1773.
Article
Google Scholar
Rolka DB, Fagot-Campagna A, Narayan KM: Aspirin use among adults with diabetes: estimates from the Third National Health and Nutrition Examination Survey. Diabetes Care. 2001, 24 (2): 197-201.
Article
CAS
PubMed
Google Scholar
Persell SD, Baker DW: Aspirin use among adults with diabetes: recent trends and emerging sex disparities. Arch Intern Med. 2004, 164 (22): 2492-2499. 10.1001/archinte.164.22.2492.
Article
PubMed
Google Scholar
Harrington RA, Becker RC, Ezekowitz M, Meade TW, O'Connor CM, Vorchheimer DA, Guyatt GH: Antithrombotic therapy for coronary artery disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004, 126 (3 Suppl): 513S-548S. 10.1378/chest.126.3_suppl.513S.
Article
CAS
PubMed
Google Scholar
McFarlane SI, Jacober SJ, Winer N, Kaur J, Castro JP, Wui MA, Gliwa A, Von Gizycki H, Sowers JR: Control of cardiovascular risk factors in patients with diabetes and hypertension at urban academic medical centers. Diabetes Care. 2002, 25 (4): 718-723.
Article
PubMed
Google Scholar
Stafford RS: Aspirin use is low among United States outpatients with coronary artery disease. Circulation. 2000, 101 (10): 1097-1101.
Article
CAS
PubMed
Google Scholar
MacLean CD, Littenberg B, Gagnon MS, Reardon M, Turner PD, Jordan C: The Vermont Diabetes Information System (VDIS): Study Design and Subject Recruitment for a Cluster Randomized Trial of a Decision Support System in a Regional Sample of Primary Care Practices. Clinical Trials. 2004, 1: 532-544. 10.1191/1740774504cn051oa.
Article
PubMed Central
PubMed
Google Scholar
ADA: Aspirin Therapy in Diabetes. Diabetes Care. 2004, 27 (Suppl 1): S72-S73.
Google Scholar
CAPRIE: A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet. 1996, 348 (9038): 1329-1339. 10.1016/S0140-6736(96)09457-3.
Article
Google Scholar
Tran H, Anand SS: Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease. Jama. 2004, 292 (15): 1867-1874. 10.1001/jama.292.15.1867.
Article
CAS
PubMed
Google Scholar
Mehta SR, Yusuf S: Short- and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention. J Am Coll Cardiol. 2003, 41 (4 Suppl S): 79S-88S. 10.1016/S0735-1097(02)02831-0.
Article
CAS
PubMed
Google Scholar
Antithrombotic_Trialists'_Collaboration: Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002, 324 (7329): 71-86.
Article
Google Scholar
Engelgau MM, Geiss LS, Saaddine JB, Boyle JP, Benjamin SM, Gregg EW, Tierney EF, Rios-Burrows N, Mokdad AH, Ford ES, Imperatore G, Narayan KM: The evolving diabetes burden in the United States. Ann Intern Med. 2004, 140 (11): 945-950.
Article
PubMed
Google Scholar
Sacco M, Pellegrini F, Roncaglioni MC, Avanzini F, Tognoni G, Nicolucci A: Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial. Diabetes Care. 2003, 26 (12): 3264-3272.
Article
CAS
PubMed
Google Scholar
Short D, Frischer M, Bashford J, Ashcroft D: Why are eligible patients not prescribed aspirin in primary care? A qualitative study indicating measures for improvement. BMC Fam Pract. 2003, 4 (1): 9-10.1186/1471-2296-4-9.
Article
PubMed Central
PubMed
Google Scholar
Tecce MA, Dasgupta I, Doherty JU: Heart disease in older women. Gender differences affect diagnosis and treatment. Geriatrics. 2003, 58 (12): 33-9.
PubMed
Google Scholar
Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, Hennekens CH, Buring JE: A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med. 2005, 352 (13): 1293-1304. 10.1056/NEJMoa050613.
Article
CAS
PubMed
Google Scholar
Diener HC, Ringleb P: Antithrombotic Secondary Prevention After Stroke. Curr Treat Options Cardiovasc Med. 2002, 4 (5): 429-440.
Article
PubMed
Google Scholar
Faulkner LA, Schauffler HH: The effect of health insurance coverage on the appropriate use of recommended clinical preventive services. Am J Prev Med. 1997, 13 (6): 453-458.
CAS
PubMed
Google Scholar
Saaddine JB, Engelgau MM, Beckles GL, Gregg EW, Thompson TJ, Narayan KM: A diabetes report card for the United States: quality of care in the 1990s. Ann Intern Med. 2002, 136 (8): 565-574.
Article
PubMed
Google Scholar
Improvement of Cardiac Outcomes in Kaiser Permanente of Ohio. The Permanente Journal. 2000, 4 (2): 78-80.
Gaede P, Vedel P, Larsen N, Jensen GV, Parving HH, Pedersen O: Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003, 348 (5): 383-393. 10.1056/NEJMoa021778.
Article
PubMed
Google Scholar
Faragon JJ, Waite NM, Hobson EH, Seoldo N, VanAmburgh JA, Migden H: Improving aspirin prophylaxis in a primary care diabetic population. Pharmacotherapy. 2003, 23 (1): 73-79. 10.1592/phco.23.1.73.31923.
Article
PubMed
Google Scholar
Haggerty SA, Cerulli J, Zeolla MM, Cottrell JS, Weck MB, Faragon JJ: Community pharmacy Target Intervention Program to improve aspirin use in persons with diabetes. J Am Pharm Assoc (Wash DC). 2005, 45 (1): 17-22.
Google Scholar
Filippi A, Sabatini A, Badioli L, Samani F, Mazzaglia G, Catapano A, Cricelli C: Effects of an automated electronic reminder in changing the antiplatelet drug-prescribing behavior among Italian general practitioners in diabetic patients: an intervention trial. Diabetes Care. 2003, 26 (5): 1497-1500.
Article
PubMed
Google Scholar
Krein SL, Vijan S, Pogach LM, Hogan MM, Kerr EA: Aspirin use and counseling about aspirin among patients with diabetes. Diabetes Care. 2002, 25 (6): 965-970.
Article
CAS
PubMed
Google Scholar